The rapid inhibition of B-cell activation markers by belimumab was associated with disease control in systemic lupus erythematosus patients

• المؤلفون الرئيسيون: Jing Wang (مؤلف), Bomiao Ju (مؤلف), Li Zhu (مؤلف), Hanchao Li (مؤلف), Jing Luo (مؤلف), Jing Zhang (مؤلف), Nan Hu (مؤلف), Lingfei Mo (مؤلف), Yanhua Wang (مؤلف), Ying Pan (مؤلف), Jing Huang (مؤلف), Xiaohong Lv (مؤلف), Dan Pu (مؤلف), Zhiming Hao (مؤلف), Lan He (مؤلف), Yuanyuan Li (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Objective: To examine the kinetics of B cell subsets and activation markers in the early stage of belimumab treatment and their correction with treatment response.Methods: We enrolled 27 systemic lupus erythematosus (SLE) patients receiving 6 months belimumab treatment. Flow cytometry was used to te...